Cabaletta Bio, Inc. · NASDAQ:CABA
Citadel Advisors LLC reported a 5.20% stake in Cabaletta Bio, Inc. (Schedule 13G)
Event Jun 12, 2025 · Filed Jun 20, 2025
Citadel Advisors LLC reported a 5.20% stake in Cabaletta Bio, Inc., 4,818,560 shares, as a passive investor on Jun 12, 2025. Filed Jun 20, 2025 (Schedule 13G).
- Stake
- 5.20%
- Shares
- 4,818,560
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Citadel Advisors LLC | 5.00% | 4,687,280 |
| Citadel Advisors Holdings LP | 5.00% | 4,687,280 |
| Citadel GP LLC | 5.00% | 4,687,280 |
| Citadel Securities LLC | 0.10% | 131,280 |
| Citadel Securities Group LP | 0.10% | 131,280 |
| Citadel Securities GP LLC | 0.10% | 131,280 |
| Kenneth Griffin | 5.20% | 4,818,560 |
Source
Related
- Cabaletta Bio, Inc.
- Citadel Advisors LLC
- Cabaletta Bio, Inc. shareholders
- Schedule 13G/A · Citadel Advisors LLC · Nov 14, 2025
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Aug 14, 2026
- Schedule 13G/A · Cormorant Asset Management, LP · Aug 14, 2026
- Schedule 13G/A · Bain Capital Life Sciences Opportunities III, LP · Aug 14, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13G · Norges Bank · Aug 12, 2026